Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
2601
-
2602
Effects of <i>B</i>. <i>erecta</i> on walking by footprint test of PD model rats.
Published 2024Subjects: -
2603
-
2604
-
2605
Effects of <i>B</i>.<i>erecta</i> on PD model rats of Depressive-like symptom.
Published 2024Subjects: -
2606
Effects of <i>B</i>. <i>erecta</i> on PD model rats of social interaction test.
Published 2024Subjects: -
2607
-
2608
-
2609
Effects of <i>B</i>. <i>erecta</i> on motor symptom of PD model rats (Rotarod test).
Published 2024Subjects: -
2610
-
2611
-
2612
-
2613
-
2614
All data used in the article.
Published 2025“…</p><p> Results </p><p><i>TGFβ1</i> expression levels, TGFβ1 and MDA concentration levels were higher in the NE compared to NE + EO and control groups (p < 0.001), and their levels decreased after EO treatment compared to the NE group (p < 0.001). …”
-
2615
Lung injury scoring system.
Published 2025“…</p><p> Results </p><p><i>TGFβ1</i> expression levels, TGFβ1 and MDA concentration levels were higher in the NE compared to NE + EO and control groups (p < 0.001), and their levels decreased after EO treatment compared to the NE group (p < 0.001). …”
-
2616
Content of EO administered to rats.
Published 2025“…</p><p> Results </p><p><i>TGFβ1</i> expression levels, TGFβ1 and MDA concentration levels were higher in the NE compared to NE + EO and control groups (p < 0.001), and their levels decreased after EO treatment compared to the NE group (p < 0.001). …”
-
2617
-
2618
-
2619
Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya.
Published 2025Subjects: -
2620